Joint Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
3analysts covering
FY Revenue (est.)
$60.3Mnext fiscal year
FY EPS (est.)
$0.28next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 5 Nov 2026 |
Monitoring Framework
Key Performance Indicators
System-wide Sales Annually532.4MTarget: $519 million to $552 million
Total Clinic Count Quarterly943Target: Net additions of 30 to 35 new franchised clinics (excluding refranchised clinics)
System-wide Comp Sales Growth Quarterly-420.0%Target: -3% to 3%
Consolidated Adjusted EBITDA Quarterly3.5MTarget: $12.5 million to $13.5 million
Watch Items
- Refranchising Progress (Joint 2.0 Initiative)Trigger: Fewer than 1% of remaining clinic portfolio being company-owned or managedAction: Monitor the final closing of the Southern California asset purchase agreement (sale of 45 clinics) to achieve pure-play franchisor status.
- Chiropractor Recruitment and Labor ShortagesTrigger: Inability to recruit or retain qualified chiropractors leading to clinic closures or higher operating costsAction: Evaluate franchise support programs, wage inflation trends, and clinic-level operational metrics.
Research as of 19 Jun 2026